OUR TEAM

<< Back to Team Members

CAROL CHERKIS - LIFE SCIENCES INDUSTRY ADVISOR

Dr. Cherkis is an expert in the field of life sciences and specializes in helping clients in that industry identify partner companies for M&A and corporate equity investments.

With over 20 years experience in business management and consulting, her diverse global client base includes startups, established companies, and Fortune 100 firms and encompasses a wide variety of health and biotechnology-related areas, including drug discovery, bioinstrumentation, medical devices, diagnostics, agriculture, food preservation, and bioremediation.

Carol's areas of business expertise include: strategic alliance formation, business development, competitive intelligence and strategic planning, organizational development, technology assessment and licensing, project management, and product development. During the last few years, her efforts have focused on formation of alliances with companies in China and Japan.

In addition to her role at NewCap Partners, she is the President of BioInfoStrategies, a biotech/medical consulting firm that she founded after a twenty-year multi-functional career with The Dow Chemical Company. Her advisory services focus on assisting small and medium-sized, fast growing companies in the genomics, proteomics, bioinformatics, biodetection/instrumentation, and biochemical reagents arenas with assessing the commercial feasibility of their technologies, developing and implementing business strategies, obtaining working capital, and establishing marketing and distribution alliances.

During 1997-98, she served as the Director of Healthcare at Frost & Sullivan, one of the largest market research firms in Silicon Valley, and implemented a successful turnaround for that division.

Carol started her career in R&D with The Dow Chemical Company. After several years as a scientist and research manager, she moved into the business functions and spent the remainder of her Dow career leading customer-focused product development efforts, establishing marketing and distribution alliances, and launching new products.

In her last position at Dow, she was the Biotechnology Program Director in the Corporate Ventures Group and had global responsibility for identifying small and medium-sized companies as sources of new technology as well as corporate partners to expedite market penetration of existing and future products. In that role, she had the opportunity to work on a broad spectrum of Life Sciences projects that were part of critical business and technology strategies in the pharmaceutical, agricultural, specialty chemicals, food packaging, medical device, and environmental industries.

In 1996, Dow sold its pharmaceutical division, Marion Merrell Dow, to Hoechst and Carol founded BioInfoStrategies and moved to California.

Dr. Cherkis has a Ph.D. in Biological Chemistry from the University of Michigan Medical School and an A.B. in Biology from Bryn Mawr College.


	OUR TEAM

	<< Back to Team Members CAROL CHERKIS - LIFE SCIENCES INDUSTRY ADVISOR Dr. Cherkis is an expert in the field of life sciences and specializes in helping clients in that industry identify partner companies for M&A and corporate equity investments. With over 20 years experience in business management and consulting, her diverse global client base includes startups, established companies, and Fortune 100 firms and encompasses a wide variety of health and biotechnology-related areas, including drug discovery, bioinstrumentation, medical devices, diagnostics, agriculture, food preservation, and bioremediation. Carol's areas of business expertise include: strategic alliance formation, business development, competitive intelligence and strategic planning, organizational development, technology assessment and licensing, project management, and product development. During the last few years, her efforts have focused on formation of alliances with companies in China and Japan. In addition to her role at NewCap Partners, she is the President of BioInfoStrategies, a biotech/medical consulting firm that she founded after a twenty-year multi-functional career with The Dow Chemical Company. Her advisory services focus on assisting small and medium-sized, fast growing companies in the genomics, proteomics, bioinformatics, biodetection/instrumentation, and biochemical reagents arenas with assessing the commercial feasibility of their technologies, developing and implementing business strategies, obtaining working capital, and establishing marketing and distribution alliances. During 1997-98, she served as the Director of Healthcare at Frost & Sullivan, one of the largest market research firms in Silicon Valley, and implemented a successful turnaround for that division. Carol started her career in R&D with The Dow Chemical Company. After several years as a scientist and research manager, she moved into the business functions and spent the remainder of her Dow career leading customer-focused product development efforts, establishing marketing and distribution alliances, and launching new products. In her last position at Dow, she was the Biotechnology Program Director in the Corporate Ventures Group and had global responsibility for identifying small and medium-sized companies as sources of new technology as well as corporate partners to expedite market penetration of existing and future products. In that role, she had the opportunity to work on a broad spectrum of Life Sciences projects that were part of critical business and technology strategies in the pharmaceutical, agricultural, specialty chemicals, food packaging, medical device, and environmental industries. In 1996, Dow sold its pharmaceutical division, Marion Merrell Dow, to Hoechst and Carol founded BioInfoStrategies and moved to California. Dr. Cherkis has a Ph.D. in Biological Chemistry from the University of Michigan Medical School and an A.B. in Biology from Bryn Mawr College.